Illumina (ILMN) Cash & Equivalents (2009 - 2026)

Illumina (ILMN) has reported Cash & Equivalents for 18 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 11.35% year-over-year to $1.0 billion; the trailing twelve-month figure through Jun 2026 stood at $1.0 billion (up 11.35% YoY), and the FY2025 full-year result was $1.4 billion, up 25.82% from the prior year.
• Cash & Equivalents fell to $1.0 billion in Q2 2026 per ILMN's latest filing, from $1.1 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $2.0 billion in Q1 2023 and bottomed at $869.0 million in Q3 2024.
• Historically, Cash & Equivalents has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents slumped 69.52% in 2022, then soared 63.23% in 2023.
• Over 5 years, Cash & Equivalents stood at $1.0 billion in 2022, then increased by 4.8% to $1.0 billion in 2023, then rose by 7.54% to $1.1 billion in 2024, then grew by 25.82% to $1.4 billion in 2025, then dropped by 26.66% to $1.0 billion in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $1.0 billion, $1.1 billion, and $1.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.